MedTrace Logo

Nutritional Assessment in Individuals with Liver Cirrhosis

NCT06588712 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-09-19

No results posted yet for this study

Summary

The risk factors for liver cirrhosis are well identified and primarily include excessive and prolonged alcohol consumption, as well as metabolic syndrome or infection with hepatitis B and C viruses. However, the factors that can predict the progression of the disease are still largely unknown. The role of nutritional factors, in particular, has been insufficiently studied in chronic liver diseases such as cirrhosis. Beyond malnutrition and nutritional deficiencies, whose roles have been well studied, it appears that other nutritional factors, such as adherence to dietary recommendations that consider the consumption of various food groups, have been little studied in patients with liver cirrhosis. Studies involving a large number of participants are essential to better describe the typical nutritional profiles of these patients, taking into account their diet, as well as their alcohol consumption and physical activity.

Therefore, the main aim of the Nutri-CIRR project is to identify and characterize typical profiles of patients with hepatic cirrhosis in terms of nutritional factors (diet, alcohol consumption and physical activity) and smoking status.

Conditions

Sponsors & Collaborators

  • Hôpital Henri Mondor, AP-HP, Unité de Recherche Clinique

    collaborator UNKNOWN

  • Hôpital Avicenne, AP-HP, Service Hépatologie

    collaborator UNKNOWN

  • Université Sorbonne Paris Nord

    lead OTHER

Principal Investigators

  • Alice Bellicha, PhD · Université Sorbonne Paris Nord

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2026-04-30
Completion
2029-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06588712 on ClinicalTrials.gov